FDA — authorised 31 October 1986
- Application: NDA018470
- Marketing authorisation holder: NOVARTIS
- Local brand name: CIBACALCIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Cibacalcin in United States
FDA authorised Cibacalcin on 31 October 1986
Marketing authorisations
FDA
- Status: approved
Cibacalcin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Cibacalcin approved in United States?
Yes. FDA authorised it on 31 October 1986; FDA has authorised it.
Who is the marketing authorisation holder for Cibacalcin in United States?
NOVARTIS holds the US marketing authorisation.